Digital strategy helps patients with heart failure to receive proven medication
A Danish study presented at the ESC Congress 2026 found that using digital registry-based strategies to identify untreated heart failure patients significantly improved the implementation of SGLT2 inhibitor therapy. The approach proactively connects patients with specialists, overcoming gaps in routine clinical care.
Why it matters
This digital health intervention offers a scalable model for improving chronic disease management and patient outcomes globally.
edited by Sadie Harley , reviewed by Andrew Zinin
This article has been reviewed according to Science X's editorial process and policies . Editors have highlighted the following attributes while ensuring the content's credibility:
Add as preferred source Credit: Unsplash/CC0 Public Domain A registry-based digital strategy that identified untreated patients and invited them to a telephone consultation more than doubled implementation of an effective treatment for heart failure. These results from the EMAIL-HF trial were presented in a Hot Line session at ESC Congress 2026.
Affecting more than 64 million individuals worldwide, heart failure is a major public health issue associated with high mortality and morbidity, poor quality of life, and high health care use and costs.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in